← Back
$ARTV All transactions

Artiva Biotherapeutics, Inc.

D

$ Value

Shares

51,463

Price

Filed

Dec 12

Insider

Name

Aslan Fred

Title

President and CEO

CIK

0001909362

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-12

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Represents restricted stock units award granted under the Issuer's 2024 Equity Incentive Plan ("RSUs"). | On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I. | 25% of the shares vested on February 22, 2022, and the remaining shares vest in 36 equal monthly installments thereafter. | 25% of the shares vest on January 1, 2022, and the remaining shares vest in 36 equal monthly installments thereafter. | Vesting is monthly over a 48-month period starting January 1, 2024 in equal monthly amounts. | 25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.

Filing Info

Accession No.

0001193125-25-317980

Form Type

4

Issuer CIK

0001817241

Aslan Fred's History

Date Ticker Type Value
2026-02-15 ARTV A $0
2026-02-15 ARTV F $58K
2025-12-15 ARTV $19K
2025-12-12 ARTV A $0
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D

Other Insiders at ARTV (90d)

Insider Bought Sold Last
Bush Jennifer
COO, CLO, Secy, Compliance Off
2026-02-15
Huston Thad Allen
Chief Financial Officer
2026-03-10
Horan Christopher
Chief Tech Operations Officer
2026-02-15
Sorg Elaine K. 2026-02-18
Aslan Fred
President and CEO
2026-02-15
Raymon Heather
SVP, Research and Development
2026-02-15
Banerjee Subhashis
Chief Medical Officer
2026-02-15